Plasma Lipid Profiles and Atherogenic Indices of Rats Fed Raw and Processed Jack Fruit (Artocarpus heterophyllus) Seeds Diets at Different Concentrations

Authors: O. E. Okafor, L. U. S. Ezeanyika, C. G. Nkwonta, C. J. Okonkwo

Abstract:

The effect of processing on plasma lipid profile and atherogenic indices of rats fed Artocarpus heterophyllus seed diets at different concentrations were investigated. Fifty five rats were used for this study, they were divided into eleven groups of five rats each (one control group and ten test groups), the test groups were fed raw, boiled, roasted, fermented and soaked diets at 10% and 40% concentrations. The study lasted for thirty five days. The diets led to significant decrease (p<0.05) in plasma cholesterol and triacylglycerol of rats fed 10% and 40% concentrations of the diets, and a significant increase (p<0.05) in high density lipoprotein (HDL) levels at 40% concentrations of the test diets. The diets also produced decrease in low density lipoprotein (LDL), very low density lipoprotein (VLDL), cardiac risk ratio (CRR), atherogenic index of plasma (AIP) and atherogenic coefficient (AC) at 40% concentrations except the soaked group that showed slight elevation of LDL, CRR, AC and AIP at 40% concentration. Artocarpus heterophyllus seeds could be beneficial to health because of its ability to increase plasma HDL and reduce plasma LDL, VLDL, cholesterol, triglycerides and atherogenic indices at higher diet concentration.

Keywords: Artocarpus heterophyllus, atherogenic indices, concentrations, lipid profile.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1107599

References:

[1] C. Gladine, et al. “Optimized rapeseed oil enriched with healthy micronutrients: a relevant nutritional approach to prevent cardiovascular diseases,” Results of the Optim'Oils randomized intervention trial. The Journal of Nutritional Biochemistry, March 2013, vol. 24, Issue 3, pp. 544–549
[2] J. Zicha, J. Kunes, and M .A. Devynck, “Abnormalities of membrane function and lipid metabolism in hypertension: a review,” Am. J. Hypertens., 1999, vol. 12, pp. 315-331.
[3] M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J. L. Chiasson, A. Garg, L. A. Holzeister, B. Hoogwerf, E. Mayer-Davies, A. D. Mooradian, J. Q. Purnell and M. Wheeler, “Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications, ” Dabetes Care, 2002, vol. 25, pp. 148-198.
[4] H. Gyling, J. A. Tuominen, V. A. Koivsto and T. A. Miettinen, “Cholesterol Metabolism in Type 1 Diabetes,” Diabetes Care, 2004, vol. 53, pp. 2217-2222.
[5] D. M. Martirosyan, L. A. Miroshnichenko, S. N. Kulokawa, A. V. Pogojeva and V. I. Zoloedov, “Amaranth oil application for heart disease and hypertension,” Lipids Health Dis., 2007, vol. 6 no. 1, doi:10.1186/1476-511X-6-1.
[6] G. X. Shen, “Lipid Disorders in Diabetes Mellitus and Current Management,” Curr. Pharmaceut. Analys., 2007, vol. 3, pp. 17-24.
[7] C. J. Ikewuchi and C. C. Ikewuchi, “Alteration of Plasma Lipid Profiles and Atherogenic Indices by Stachytarpheta jamaicensis L. (Vahl),” Biokemistri, 2009, vol. 21, pp. 71-77.
[8] F.B. Hu, J.E. Manson, W.C. Willett, “Types of dietary fat and risk of coronary heart disease: A critical review,” J. Am. Coll. Nutr, 2001, vol. 20, pp. 5–19.
[9] C. Manach, A. Mazur, A. Scalbert, “Polyphenols and prevention of cardiovascular diseases,” Curr Opin Lipidol, 2005, vol. 16, pp. 77–84.
[10] M. R. Fernando, M. I. Thabrew and E. H. Karunanayake, “Hypoglycaemic activity of some medicinal plants in Sri-Lanka,” General Pharmacology, 1990, vol. 21, pp. 779−782.
[11] M. Sato, S. Fujiwara, H. Tsuchiya, T. Fujii, M. Iinuma, H. Tosa, “Flavones with antibacterial activity against cariogenic bacteria,” Journal of Ethnopharmacology, 1996, vol. 54, pp. 171−176.
[12] U. B. Jagtap, S. N. Panaskar, and V. A. Bapat, “Evaluation of antioxidant capacity and phenol content in jackfruit (Artocarpus heterophyllus Lam.) fruit pulp, ” Plant Foods for Human Nutrition, 2010, vol. 65, pp. 99−104.
[13] S.B. Manjeshwar et al, “Phytochemistry, nutritional and pharmacological properties of Artocarpus heterophyllus Lam (jackfruit): A review,” Food Research International, 2011, vol. 44, pp. 1800–1811.
[14] W. T. Friedewald, R. I. Levy, and D. S. Friedrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge”. Clin. Chem. 1972, vol. 18, pp. 499-502.
[15] M. R. Law, “Lowering heart disease risk with cholesterol reduction: evidence from observational studies and clinical trials,” Eur. Heart J. Suppl., 1999, vol. 1, pp. S3-S8.
[16] O. Ademuyiwa, R. N. Ugbaja, I F. Dumebor, and O. Adebawo, “Plasma lipid profiles and risk of cardiovascular disease in occupational lead exposure in Abeokuta, Nigeria,” Lipids Health Dis., 2005, vol. 4, pp. 19.
[17] E. Jr . Middleton, C. Kandaswami, and T.C. Theoharides, “The Effects of Plant Flavonoids on Mammalian Cells: Implications for Inflammation, Heart Disease and Cancer,” Pharmacol. Rev., 2000, vol. 52, pp. 673-751.
[18] American Dietetic Association, “Disorders of Lipid Metabolism Evidence-Based Nutrition Practice Guideline,” American Dietetic Association, Chicago (IL), August 2005, 17p.
[19] P. E. McBride, “Triglycerides and Risk for Coronary Heart Disease,” J.A.M.A., 2007, vol. 298, pp. 336-338.
[20] D. K. Das, “Cardioprotection with high density lipoproteins. Fact or Fiction?,” Cir. Res., 2003, vol. 92, pp. 258-260.
[21] G.Assmann and A. M. Jr. Gotto, “HDL Cholesterol and Protective Factors in Atherosclerosis,” Circulation, 2004, vol. 109, (suppl III): III-8 –III-14.
[22] B.J. Ansell, K.E. Watson, A.M. Fogelman, M. Navab, and G.C. Fonarow, “High-density lipoprotein function - Recent advances,” J Am Coll Cardiol, 2005, vol. 46, pp. 1792–1798.
[23] J. Frohlich and M. Dobiásová, “Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings in Coronary Angiography,” Clin. Chem., 2003, vol. 49, pp. 1873-1880.
[24] A. Brehm, G. Pfeiler, G. Pacini, H. Vierhapper and M. Roden, “Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity,” Clin. Chem., 2004, vol. 50, pp. 2316–2322.
[25] M. Dobiásová, “Atherogenic Index of Plasma (log(triglyceride/HDLCholesterol): Theoretical and Practical Implications,” Clin. Chem., 2004, vol. 50, pp. 1113-1115.
[26] Y. Takasaki, “Serum Lipid Levels and Factors Affecting atherogenic Index in Japanese Children,” J. Physiol. Anthropol. Appl. Human. Sci., 2005, vol. 24, pp. 511-515.
[27] C. A. O. Usoro, C. C. Adikwuru, I. N. Usoro and A. C. Nsonwu, “Lipid Profile of Postmenopausal Women in Calabar, Nigeria,” Pak. J. Nutr. 2006, vol. 5, pp. 79-82.